Back to today’s briefing

Story perspectives

Yale and Connecticut Halt Gender Meds, Sparking Outrage

7/30/2025

43 6

Center

Yale Halts Medications

Yale Medicine and Connecticut Children's Hospital have halted gender-affirming medications for patients under 19, bowing to federal pressures. This decision has sparked outrage among parents, who worry about their children's health, while activists decry the move as a political maneuver that undermines essential care for youth navigating their identities.

Right

Trump's Order Halts Treatments

A wave of hospitals in the U.S. have halted gender-related medical treatments for minors, spurred by President Trump's executive order targeting "child sexual mutilation." This move jeopardizes federal funding for those facilities, igniting fierce debate. Critics warn that this political maneuver jeopardizes the health and future of vulnerable youth, prioritizing agendas over essential care.

History

Historical Context

In 1973, the American Psychiatric Association declassified homosexuality as a mental disorder, catalyzing advancements in LGBTQ+ rights and healthcare. This shift fostered advocacy for gender-affirming care, supported by organizations like the Human Rights Campaign. However, recent bans on such care in 18 states, influenced by political figures, threaten the well-being of transgender youth, raising concerns about healthcare politicization.

1 of 3

Yale Halts Medications

Yale Medicine and Connecticut Children's Hospital have halted gender-affirming medications for patients under 19, bowing to federal pressures. This decision has sparked outrage among parents, who worry about their children's health, while activists decry the move as a political maneuver that undermines essential care for youth navigating their identities.

1 / 3